KEGG   DRUG: Sipuleucel-THelp
Entry
D06644                      Drug                                   

Name
Sipuleucel-T (USAN);
Provenge (TN)
Product
Remark
ATC code: L03AX17
Product: D06644<US>
Efficacy
Antineoplastic, Autologous CD54+ cell
  Disease
Prostate cancer, castrate-resistant [DS:H00024]
Comment
Cellular therapy product
Cancer vaccine (Product is a specific actie immunotherapeutic composed of antigen-loaded autologous antigen presenting cells designed to stimulate a T cell immune response specific for the tumor associated antigen prostatic acid phosphatase.)
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L03 IMMUNOSTIMULANTS
   L03A IMMUNOSTIMULANTS
    L03AX Other immunostimulants
     L03AX17 Sipuleucel-T
      D06644  Sipuleucel-T (USAN) <US>
New drug approvals in the USA [br08319.html]
 Cellular and gene therapy products
  D06644
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D06644
BRITE hierarchy
Other DBs
CAS: 917381-47-6
PubChem: 47208295
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system